Takeshi Ueda

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Bernard Escudier, Saby George et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text

Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways

Takeshi Ueda, Nicholas Bruchovsky, Marianne D. Sadar · Journal of Biological Chemistry · 2002 · 380 citations · Full text

Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells

Takeshi Ueda, Nasrin R. Mawji, Nicholas Bruchovsky et al. · Journal of Biological Chemistry · 2002 · 304 citations · Full text

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Masato Sasaki, Christiane B. Knobbe‐Thomsen, Momoe Itsumi et al. · Genes & Development · 2012 · 296 citations · Full text

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

Bernard Escudier, Padmanee Sharma, David F. McDermott et al. · European Urology · 2017 · 247 citations · Full text

Checkmate 025, Urology, Prior Therapy +10